Year: 2014

Uncertainty of Ebola Concerns Princeton Citizens, Prompts Policies

Uncertainty of Ebola Concerns Princeton Citizens, Prompts Policies

The Ebola outbreak has resulted in global panic, making citizens question the safety of everything from public transportation to crowded events. Recent developments have brought the crisis directly to Princeton. On October 1st, NBC cameraman Alexander Mukpo contracted Ebola while cleaning a car that had […]

Editorial: Ebola

Editorial: Ebola

The American public, along with state and federal government officials, had sufficient cause to be frightened when the first case of Ebola knocked at its doorsteps. Amidst the panic and frenzy in response to the Ebola outbreak, a controversial quarantine was issued against 33-year-old nurse […]

Valley Fever: The Mysterious Fungus Infecting the Southwest without a Vaccine or Cure

Valley Fever: The Mysterious Fungus Infecting the Southwest without a Vaccine or Cure

Valley Fever or Coccidioidomycosis, also known as cocci, is a fungal disease endemic to the soils of the Southwest. Around 60% of those exposed never have symptoms. The majority of the other 40% have flu-like symptoms. About 5 to 10% of those exposed develop serious […]

Ebola and Cultural Misunderstandings

Ebola and Cultural Misunderstandings

The spread of the Ebola virus in West Africa has generated fear over the possible global spread of the disease due to traveling, improper health care, and the potential transmission of disease through bodily fluid exchange or, less likely, airborne contamination. Experts generally trace the […]

EXCLUSIVE: Interview with the CDC on the Approval of New Meningitis Vaccine

EXCLUSIVE: Interview with the CDC on the Approval of New Meningitis Vaccine

Last year, almost all of the Princeton students received two doses of the meningitis B vaccine called Bexsero, which was developed by Novartis. Bexsero, while not formally approved by the FDA in the US, had been approved in other nations globally and as a result, […]

Approving Trumenba: Why Not Bexsero?

Approving Trumenba: Why Not Bexsero?

Last Wednesday, the FDA approved a vaccine for Meningitis B1,2, the same strain of bacterial meningitis that Princeton students faced last year. Yet the newly-approved drug is not Novartis’ Bexsero, which thousands of students at Princeton and UCSB have received in the past year. Instead, […]

Hear from the scientist who discovered the meningitis vaccine

Hear from the scientist who discovered the meningitis vaccine

Don’t miss this chance to listen to and speak with Dr. Rappuoli, the developer of the Meningitis B vaccine that you received last winter! It will be an incredible lecture that you don’t want to miss with a Q&A session designed to give students an opportunity to engage […]

Meningitis Forum–Get Your Questions Answered

Meningitis Forum–Get Your Questions Answered

Want your questions about meningitis answered? After reviewing the literature, consulting information from the CDC, and/or speaking with experts, an editor from PPHR will respond to posts on this page within 48 hours. We encourage all questions as well as a productive discussion about the […]